Physician profile
Nicholas C Rizos
NPI 1093736407
$2,291.92
in general payments reported to CMS, 2019-2025
10 companies · $1,262 in 2025
The $1,262 reported for 2025 was more than what 97% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $366 · 2023: $116 · 2024: $298 · 2025: $1,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $983 · Education: $450 · Food and Beverage: $200 · Honoraria: $42.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $983.49 |
| Education | $450.00 |
| Food and Beverage | $199.91 |
| Honoraria | $42.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $693.00 | 2025 | |
| Ultradent Products INC | $639.95 | 2021-2025 | Opalescence |
| Dentsply Sirona INC | $349.83 | 2021-2025 | Implant Dentistry, Astra Tech Implant System |
| Straumann USA LLC | $250.00 | 2024-2025 | |
| Zimvie INC. | $200.00 | 2023-2025 | |
| Align Technology, INC. | $69.16 | 2022 | |
| Benco Dental Supply Co. | $42.26 | 2025 | |
| Philips North America LLC | $17.84 | 2024 | (E55) Oral Health Care Und |
| 3m Company | $15.93 | 2023 | Vanish, Scotchbond Universal Plus, 3m Relyx |
| Orapharma, A Division of Bausch Health US, LLC | $13.95 | 2025 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Rizos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.